Joseph G Timpa
Overview
Explore the profile of Joseph G Timpa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan C, Mauchley D, Byrnes J, Carlo W, Law M, OMeara L, et al.
ASAIO J
. 2020 Nov;
67(7):e124-e126.
PMID: 33148980
We report a successful pediatric bridge to transplant following application of the ProTekDuo Cannula to provide right ventricular support in a 12-year-old child with biventricular cardiomyopathy and on left ventricular...
2.
Riley J, Lucas M, Samolyk K, Reagor J, Timpa J, Pierce C, et al.
J Extra Corpor Technol
. 2020 Jul;
52(2):96-102.
PMID: 32669735
The American Society of Extracorporeal Technology Board of Directors, consistent with the American Society of Extracorporeal Technology's safe patient care improvement mission, charged the International Board of Blood Management to...
3.
Borasino S, Kalra Y, Elam A, Carlisle OMeara L, Timpa J, Goldberg K, et al.
J Extra Corpor Technol
. 2018 Dec;
50(4):217-224.
PMID: 30581228
Intravascular hemolysis with elevated plasma-free hemoglobin (PFH) complicates extracorporeal membrane oxygenation (ECMO). In 50 consecutive pediatric cardiac patients requiring ECMO, we sought to describe the relationship between PFH and clinical...
4.
Townsley M, Timpa J, Davies Jr J, Marques M
Anesth Analg
. 2017 Aug;
125(3):731-733.
PMID: 28817529
No abstract available.
5.
Timpa J, OMeara L, Goldberg K, Phillips J, Crawford J, Jackson K, et al.
J Extra Corpor Technol
. 2016 May;
48(1):11-8.
PMID: 27134303
Perioperative transfusion of blood products is associated with increased morbidity and mortality after pediatric cardiac surgery. We report the results of a quality improvement project aimed at decreasing perioperative blood...
6.
Rhodes L, Sasser W, McMahon W, Law M, Timpa J, OMeara L, et al.
ASAIO J
. 2015 Feb;
61(4):e29-30.
PMID: 25710775
Limited vascular access because of vessel injury or thrombosis may complicate care of children with congenital heart disease. Although transhepatic venous access for cardiac catheterization and central venous catheter placement...
7.
OMeara L, Alten J, Goldberg K, Timpa J, Phillips J, Laney D, et al.
ASAIO J
. 2015 Feb;
61(3):339-44.
PMID: 25710768
The optimum heparin monitoring method during extracorporeal membrane oxygenation (ECMO) is unknown. We report a protocol utilizing only anti-factor Xa (anti-Xa) to manage anticoagulation in 22 consecutive ECMO patients. Anti-Xa...
8.
MohanKumar K, Killingsworth C, McIlwain R, Timpa J, Jagadeeswaran R, Namachivayam K, et al.
Lab Invest
. 2013 Dec;
94(2):150-60.
PMID: 24365747
Neonates and young infants exposed to extracorporeal circulation during extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass are at risk of developing a systemic inflammatory response syndrome with multi-organ dysfunction. We...
9.
Zaccagni H, Timpa J, OMeara L, Alten J
Interact Cardiovasc Thorac Surg
. 2013 Apr;
17(1):196-8.
PMID: 23571680
Ventricular assist devices (VADs) are used in children with severe heart failure as a bridge to heart transplantation or recovery. Severe pulmonary dysfunction may preclude their use, leaving extracorporeal membrane...
10.
Timpa J, OMeara C, McIlwain R, Dabal R, Alten J
J Extra Corpor Technol
. 2011 Aug;
43(2):86-8.
PMID: 21848179
Extracorporeal membrane oxygenation (ECMO) is universally accepted as a potential lifesaving therapy for neonates suffering severe cardiorespiratory failure, with survival reported as 81% weaning off ECMO and 69% to hospital...